Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALT NYSE:AMT NYSE:FPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALTAltimmune$3.87+8.4%$3.76$2.90▼$11.16$315.08M0.182.21 million shs6.49 million shsAMTAmerican Tower$193.01-2.1%$208.70$172.51▼$238.34$92.35B0.862.90 million shs2.37 million shsFPHFive Point$6.50+1.4%$5.76$3.13▼$6.71$955.70M1.55142,315 shs155,047 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALTAltimmune+8.40%+4.88%+6.91%-45.09%-47.91%AMTAmerican Tower-2.04%-1.75%-6.56%-11.15%-18.20%FPHFive Point+1.09%+8.70%+18.29%+18.07%+93.45%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALTAltimmune$3.87+8.4%$3.76$2.90▼$11.16$315.08M0.182.21 million shs6.49 million shsAMTAmerican Tower$193.01-2.1%$208.70$172.51▼$238.34$92.35B0.862.90 million shs2.37 million shsFPHFive Point$6.50+1.4%$5.76$3.13▼$6.71$955.70M1.55142,315 shs155,047 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALTAltimmune+8.40%+4.88%+6.91%-45.09%-47.91%AMTAmerican Tower-2.04%-1.75%-6.56%-11.15%-18.20%FPHFive Point+1.09%+8.70%+18.29%+18.07%+93.45%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALTAltimmune 2.57Moderate Buy$17.40349.61% UpsideAMTAmerican Tower 2.94Moderate Buy$244.7326.80% UpsideFPHFive Point 3.00BuyN/AN/ACurrent Analyst Ratings BreakdownLatest FPH, ADR, AMT, and ALT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$246.00 ➝ $250.008/13/2025ALTAltimmuneHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.008/13/2025ALTAltimmuneUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$26.00 ➝ $24.008/13/2025ALTAltimmuneB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.00 ➝ $18.007/31/2025AMTAmerican TowerRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$250.00 ➝ $260.007/30/2025AMTAmerican TowerHsbc Global ResSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/30/2025AMTAmerican TowerRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetStrong-Buy$251.00 ➝ $250.007/30/2025AMTAmerican TowerWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$240.00 ➝ $230.007/30/2025AMTAmerican TowerJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$250.00 ➝ $255.007/30/2025AMTAmerican TowerBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$250.00 ➝ $245.007/30/2025AMTAmerican TowerHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$235.00(Data available from 9/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALTAltimmune$20K17,077.73N/AN/A$1.74 per share2.22AMTAmerican Tower$10.26B8.81$11.33 per share17.03$20.64 per share9.35FPHFive Point$197.43M4.91$0.60 per share10.87$14.50 per share0.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALTAltimmune-$95.06M-$1.18N/AN/AN/A-438,730.03%-62.63%-55.29%11/11/2025 (Estimated)AMTAmerican Tower$2.26B$2.7570.1919.301.2212.60%24.85%4.01%11/4/2025 (Estimated)FPHFive Point$68.30M$1.095.96∞N/A39.43%3.61%2.52%10/16/2025 (Estimated)Latest FPH, ADR, AMT, and ALT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025ALTAltimmune-$0.32-$0.27+$0.05-$0.27$0.00 million$0.01 million7/29/2025Q2 2025AMTAmerican Tower$2.59$2.60+$0.01$2.60$2.58 billion$2.63 billion7/24/2025Q2 2025FPHFive PointN/A$0.05N/A$0.05N/A$7.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALTAltimmuneN/AN/AN/AN/AN/AAMTAmerican Tower$6.803.52%N/A247.27%1 YearsFPHFive PointN/AN/AN/AN/AN/ALatest FPH, ADR, AMT, and ALT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/18/2025AMTAmerican Towerquarterly$1.703.52%9/30/20259/30/202510/20/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALTAltimmune0.0920.4420.44AMTAmerican Tower3.360.950.95FPHFive PointN/A0.730.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALTAltimmune78.05%AMTAmerican Tower92.69%FPHFive Point38.09%Insider OwnershipCompanyInsider OwnershipALTAltimmune4.40%AMTAmerican Tower0.17%FPHFive Point21.49%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALTAltimmune5088.26 million84.37 millionOptionableAMTAmerican Tower4,691468.25 million467.46 millionOptionableFPHFive Point100149.10 million117.05 millionNot OptionableFPH, ADR, AMT, and ALT HeadlinesRecent News About These CompaniesFive Point-backed WaterBridge valued at nearly $3 billion as shares jump in NYSE debutSeptember 17 at 6:00 PM | msn.comFive Point Holdings prices debt offering of $450M via issuance of senior notesSeptember 16 at 10:24 AM | msn.comFive Point Announces Pricing of $450 Million of Senior Notes by Five Point Operating Company, LPSeptember 15, 2025 | businesswire.comFive Point Holdings Launches $450 Million Notes OfferingSeptember 15, 2025 | msn.comMoody’s upgrades Five Point’s rating to B2, assigns B2 to new notesSeptember 15, 2025 | au.investing.comFive Point Announces Cash Tender Offer for Any and All Outstanding 10.500% Initial Rate Senior Notes Due 2028September 15, 2025 | businesswire.comFive Point Announces Proposed Offering of $450.0 Million of Senior Notes by Five Point Operating Company, LPSeptember 15, 2025 | businesswire.comMilitia Capital Partners LP Has $1.49 Million Holdings in Five Point Holdings, LLC $FPHSeptember 14, 2025 | marketbeat.comFive Point Holdings, LLC $FPH Shares Bought by Cubist Systematic Strategies LLCSeptember 12, 2025 | marketbeat.comTrexquant Investment LP Invests $254,000 in Five Point Holdings, LLC $FPHSeptember 12, 2025 | marketbeat.comEvaluation Of Five Point Holdings After Its Impressive RallySeptember 9, 2025 | seekingalpha.comFive Point Holdings Updates Strategic Corporate PresentationSeptember 8, 2025 | msn.comAmerican Century Companies Inc. Increases Stock Position in Five Point Holdings, LLC $FPHSeptember 8, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 142,166 Shares of Five Point Holdings, LLC $FPHSeptember 5, 2025 | marketbeat.comCorsair Capital Management L.P. Purchases Shares of 90,021 Five Point Holdings, LLC $FPHAugust 31, 2025 | marketbeat.comWellington Management Group LLP Has $5.51 Million Stock Holdings in Five Point Holdings, LLC $FPHAugust 31, 2025 | marketbeat.comGlendon Capital Management LP Sells 50,000 Shares of Five Point Holdings, LLC $FPHAugust 24, 2025 | marketbeat.comFive Point Holdings Amends Development Agreement for Key SitesAugust 12, 2025 | msn.comFive Point Holdings, LLC (NYSE:FPH) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | msn.comFive Point Holdings Second Quarter 2025 Earnings: EPS: US$0.022 (vs US$0.21 in 2Q 2024)July 26, 2025 | finance.yahoo.comFive Point anticipates year-end net income in line with $177.6M 2024 result while advancing Hearthstone acquisitionJuly 25, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Chevron Stock Outlook: Dividend Growth Meets InflationBy Chris Markoch | August 28, 2025CoreWeave and Madrigal's Insider Trades Flash Bullish SignalsBy Leo Miller | September 10, 2025FPH, ADR, AMT, and ALT Company DescriptionsAltimmune NASDAQ:ALT$3.87 +0.30 (+8.40%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$3.88 +0.01 (+0.36%) As of 05:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.American Tower NYSE:AMT$193.01 -4.21 (-2.13%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$193.01 0.00 (0.00%) As of 05:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.Five Point NYSE:FPH$6.50 +0.09 (+1.40%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$6.50 +0.00 (+0.08%) As of 09/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Five Point Holdings, LLC, through its subsidiary, Five Point Operating Company, LP, owns and develops mixed-use and planned communities in Orange County, Los Angeles County, and San Francisco County. The company operates in four segments: Valencia, San Francisco, Great Park, and Commercial. It sells residential and commercial land sites to homebuilders, commercial developers, and commercial buyers; operates and owns a commercial office, research and development, medical campus, and other properties; and provides development and property management services. The company was formerly known as Newhall Holding Company, LLC and changed its name to Five Point Holdings, LLC in May 2016. Five Point Holdings, LLC was incorporated in 2009 and is headquartered in Irvine, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything Bloom Energy Booms on AI Power Demand and Analyst Upgrades Can Apple’s iPhone 17 and AI Push Its Stock to New Highs? Why Seagate Is Wall Street's New Favorite AI Infrastructure Play New Catalysts Build Positive Pressure on Intel Stock Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why General Mills Is a Generational Opportunity for Income Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
